New technology platform reaffirms ICON as the CRO industry’s pre-eminent provider of adaptive clinical trial services Dublin, Ireland, 19th January, 2015 – ICON plc, ...

The validation program is the latest milestone driving the rapid adoption of the new approach January 11, 2016, Rochester, NY  -  iCardiac Technologies, Inc., a scien...

Complimentary Live Webinar: "Optimizing Your Clinical Supply Chain Strategy for Asia-Pacific Studies"   Join us on Thursday, January 28th, 10:00 a...

The stem cell disease model specialists recruit leading biologist, Prof Xianmin Zeng as Chief Scientific Officer   Cambridge, UK, 12 January 2016: Axol Bioscienc...

After almost two years on the auction block, Novartis' ($NVS) manufacturing facility in Suffern, NY, is likely to be sold by the end of this winter as two developers...

ScHARR completes independent, scientific, peer reviewed study, funded by Exco InTouch, comparing EQ-5D-5L equivalence across mobile phone and paper administration mod...